Saturday 7 November 2026 Export LXRX’s income statement to Excel — free account

Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $49.8 million, up 60.2% from fiscal 2024.

Revenue: −20.7%
EPS: +21.3%
Free cash flow: +66.1%
Total debt: −8.17%

Quarter to September 2026, against a year earlier

1.79 0.18 +11.18%

Follow LXRX

Alert me

Market cap: $716.4M
P/E: 0.0×
Fwd P/E: −8.4×
Dividend yield: —
F-score: 4/9
Altman Z: −12.11
Beneish M: −1.17
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26 From the 10-Q filed 5 Nov
ROE Full definition →	+8 more TTM periods Free account	(39.72%)	(16.01%)	(40.21%)	(43.91%)
Piotroski F-Score Full definition →		4	4	2	2
ROA Full definition →		(20.83%)	(9.21%)	(25.70%)	(27.84%)
ROIC Full definition →		(46.81%)	(18.49%)	(96.36%)	(109.13%)
Return on Tangible Assets Full definition →		(60.73%)	(14.67%)	(33.30%)	(36.12%)
Average Days of Receivables Full definition →		17.47	61.73	14.46	16.83
Free Cash Flow per Share Full definition →		(0.19)	(0.10)	(0.15)	(0.11)
Free Cash Flow Full definition →		(67.85)	(38.80)	(64.99)	(49.23)
Other line items
Cash ROIC Full definition →		(26.32%)	(9.17%)	(15.60%)	(12.34%)
Accounts Receivable Turnover Full definition →		17.01	2.35	21.68	18.75
Accounts Payable Turnover Full definition →		0.03	0.05	0.09	0.11
Inventory Turnover Full definition →		1.07	1.48	0.52	0.63
Average Days of Payables Full definition →		4,106.92	3,106.65	2,388.81	3,628.63
Days of Inventory on Hand Full definition →		374.32	286.19	1,219.39	1,030.89
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		122.73%	84.11%	145.34%	149.77%
Selling, General and Administrative Expense of Revenue Full definition →		74.93%	50.18%	85.23%	96.54%
Share Based Compensation of Revenue Full definition →		25.13%	18.02%	30.61%	32.78%
Interest Coverage Full definition →		(5.87)	(2.99)	(6.50)	(7.72)
Operating CF/Net income Full definition →		1.35	1.49	1.06	0.79
Depreciation/Fixed assets Full definition →		1.25	1.45	1.57	1.66
Capex/Depreciation Full definition →		0.00	0.00	0.00	0.00
Revenue per Share Full definition →		0.14	0.17	0.09	0.09
Operating CF per Share Full definition →		(0.19)	(0.10)	(0.15)	(0.11)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly